Silymarin for nerve protection and symptom control in Parkinson's
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if silymarin, a natural plant extract, can help protect nerves and improve symptoms in people with Parkinson's disease who are already taking dopamine replacement therapy. It aims to see if adding silymarin can provide extra benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 65 years old.
- You have been diagnosed with Parkinson's disease and are taking medication that replaces dopamine.
- Your Parkinson's disease is at a stage 1 to 4 on the Modified Hoehn and Yahr scale (mild to moderate).
- You are not pregnant or breastfeeding.
- You do not have severe liver disease, morbid obesity (BMI over 40), or poorly controlled diabetes (HbA1C over 7%).
- You have not taken silymarin or multivitamins containing it in the past two weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if metformin, a diabetes drug, can help people with Parkinson's disease. It may improve symptoms or slow progression.
This trial tests whether a Mediterranean diet can help people with Parkinson's disease. You would either follow your usual diet or switch to a Mediterranean diet for six months and provide blood and stool samples.
This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.
This trial is testing if a medicine called tenofovir, usually used for HIV and hepatitis B, can help people with early-stage Parkinson's disease. It's for people who are under 65 and have no other major health issues.
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
This study tests an injectable antibody called LY4006896, first in healthy volunteers and then in people with Parkinson's disease. It aims to see if the drug is safe and how it works in the body.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.